Panthera Biopartners has become the first UK public or commercial clinical trial organization to become part of the Parexel Site Alliance Vaccine Network, a global network of high-performing clinical trial sites that fosters long-term collaborative relationships with select research organizations across the globe to deliver efficiencies to patients, sites and their biopharmaceutical customers.   Panthera was selected to join the Site Alliance Vaccine Network due to its exceptional performance ...